320 related articles for article (PubMed ID: 9211570)
21. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Lecrubier Y; Guelfi JD
Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
[TBL] [Abstract][Full Text] [Related]
22. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
Birkenhäger TK; Vegt M; Nolen WA
Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
[TBL] [Abstract][Full Text] [Related]
23. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
Versiani M; Nardi AE; Figueira IL; Stabl M
Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
[TBL] [Abstract][Full Text] [Related]
24. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
Stabl M; Biziére K; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
[TBL] [Abstract][Full Text] [Related]
25. The role of moclobemide in endogenous depression: a survey of recent data.
Woggon B
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):137-9. PubMed ID: 8468434
[TBL] [Abstract][Full Text] [Related]
26. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
27. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
Casacchia M; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
[TBL] [Abstract][Full Text] [Related]
28. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
Bizière K; Berger M
Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
[TBL] [Abstract][Full Text] [Related]
30. Double-blind comparison of moclobemide and tranylcypromine in depression.
Heinze G; Rossel L; Gabelic I; Galeano-Munoz J; Stabl M; Allen SR
Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression.
Paykel ES
Acta Psychiatr Scand Suppl; 1995; 386():22-7. PubMed ID: 7717091
[TBL] [Abstract][Full Text] [Related]
32. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
[TBL] [Abstract][Full Text] [Related]
33. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
Laux G; Beckmann H; Classen W; Becker T
J Neural Transm Suppl; 1989; 28():45-52. PubMed ID: 2677241
[TBL] [Abstract][Full Text] [Related]
34. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
Stassen HH; Angst J; Delini-Stula A
Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
[TBL] [Abstract][Full Text] [Related]
35. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
Funke HJ; Moritz E; Hellstern K; Malanowski H
Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069
[TBL] [Abstract][Full Text] [Related]
36. Moclobemide (Aurorix) in primary major depression.
Rihmer Z; Barsi J; Vad G; György S; Zalay B; Vég K; Gábor A
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):367-72. PubMed ID: 8208985
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of tardive akathisia with moclobemide, a reversible and selective monoamine-oxidase-A inhibitor. A case study.
Ebert D; Demling J
Pharmacopsychiatry; 1991 Nov; 24(6):229-31. PubMed ID: 1687486
[TBL] [Abstract][Full Text] [Related]
38. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
[TBL] [Abstract][Full Text] [Related]
39. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.
Casacchia M; Carolei A; Barba C; Frontoni M; Rossi A; Meco G; Zylberman MR
Pharmacopsychiatry; 1984 Jul; 17(4):122-5. PubMed ID: 6382361
[TBL] [Abstract][Full Text] [Related]
40. Tricyclic nonresponders: phenomenology and treatment.
Roose SP; Glassman AH; Walsh BT; Woodring S
Am J Psychiatry; 1986 Mar; 143(3):345-8. PubMed ID: 3953869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
